ID PO2F3_RAT Reviewed; 430 AA. AC P42571; A0A8I6A0U7; P42572; DT 01-NOV-1995, integrated into UniProtKB/Swiss-Prot. DT 14-DEC-2022, sequence version 2. DT 24-JAN-2024, entry version 156. DE RecName: Full=POU domain, class 2, transcription factor 3; DE AltName: Full=Octamer-binding protein 11; DE Short=Oct-11; DE AltName: Full=Octamer-binding transcription factor 11; DE Short=OTF-11; DE AltName: Full=Transcription factor Skn-1; GN Name=Pou2f3; Synonyms=Otf11, Skn-1, Skn1; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Rattus. OX NCBI_TaxID=10116; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND FUNCTION (ISOFORMS 1 RP AND 2). RC STRAIN=Fischer; TISSUE=Skin; RX PubMed=7682011; DOI=10.1126/science.7682011; RA Andersen B., Schonemann M.D., Flynn S.E., Pearse R.V. II, Singh H., RA Rosenfeld M.G.; RT "Skn-1a and Skn-1i: two functionally distinct Oct-2-related factors RT expressed in epidermis."; RL Science 260:78-82(1993). RN [2] RP ERRATUM OF PUBMED:7682011. RX PubMed=8248794; RA Andersen B., Schonemann M.D., Flynn S.E., Pearse R.V. II, Singh H., RA Rosenfeld M.G.; RL Science 262:1499-1499(1993). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=Brown Norway; RX PubMed=15057822; DOI=10.1038/nature02426; RA Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J., RA Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G., RA Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G., RA Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G., RA Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S., RA Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T., RA Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D., RA Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L., RA Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D., RA Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M., RA Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C., RA Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J., RA Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H., RA Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X., RA Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q., RA Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P., RA Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A., RA Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C., RA Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J., RA Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J., RA Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F., RA Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A., RA Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A., RA Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J., RA Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E., RA Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M., RA Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C., RA Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L., RA Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W., RA Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y., RA Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V., RA Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M., RA Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S., RA Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B., RA Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R., RA Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J., RA Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D., RA Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S., RA Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S., RA Mockrin S., Collins F.S.; RT "Genome sequence of the Brown Norway rat yields insights into mammalian RT evolution."; RL Nature 428:493-521(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Transcription factor that binds to the octamer motif (5'- CC ATTTGCAT-3') and regulates cell type-specific differentiation pathways. CC Involved in the regulation of keratinocytes differentiation CC (PubMed:7682011). The POU2F3-POU2AF2/POU2AF3 complex drives the CC expression of tuft-cell-specific genes, a rare chemosensory cells that CC coordinate immune and neural functions within mucosal epithelial CC tissues (By similarity). {ECO:0000250|UniProtKB:Q9UKI9, CC ECO:0000269|PubMed:7682011}. CC -!- FUNCTION: [Isoform 2]: Inhibits transactivation by POU2F1. CC {ECO:0000269|PubMed:7682011}. CC -!- SUBUNIT: Interacts (via the POU domain) with POU2AF1 and POU2AF2 in a CC DNA-dependent manner; this interaction recruits POU2AF2 to chromatin CC and increases POU2F3 transactivation activity. CC {ECO:0000250|UniProtKB:Q9UKI9}. CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P31362}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; Synonyms=Skn-1a {ECO:0000303|PubMed:7682011}; CC IsoId=P42571-1; Sequence=Displayed; CC Name=2; Synonyms=Skn-1i {ECO:0000303|PubMed:7682011}; CC IsoId=P42571-2; Sequence=VSP_002332; CC -!- TISSUE SPECIFICITY: Expressed in epidermis and hair follicles. CC {ECO:0000269|PubMed:7682011}. CC -!- SIMILARITY: Belongs to the POU transcription factor family. Class-2 CC subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; L23862; -; NOT_ANNOTATED_CDS; mRNA. DR EMBL; L23863; -; NOT_ANNOTATED_CDS; mRNA. DR EMBL; CH473975; EDL95261.1; -; Genomic_DNA. DR PIR; A46216; A46216. DR RefSeq; NP_001099215.1; NM_001105745.1. [P42571-1] DR AlphaFoldDB; P42571; -. DR SMR; P42571; -. DR STRING; 10116.ENSRNOP00000012170; -. DR PhosphoSitePlus; P42571; -. DR PaxDb; 10116-ENSRNOP00000012170; -. DR Ensembl; ENSRNOT00000107784.1; ENSRNOP00000084235.1; ENSRNOG00000009118.7. [P42571-1] DR Ensembl; ENSRNOT00055033337; ENSRNOP00055027048; ENSRNOG00055019514. [P42571-1] DR Ensembl; ENSRNOT00060037565; ENSRNOP00060030961; ENSRNOG00060021548. [P42571-1] DR Ensembl; ENSRNOT00065044129; ENSRNOP00065036211; ENSRNOG00065025576. [P42571-1] DR GeneID; 116544; -. DR KEGG; rno:116544; -. DR UCSC; RGD:621691; rat. [P42571-1] DR AGR; RGD:621691; -. DR CTD; 25833; -. DR RGD; 621691; Pou2f3. DR eggNOG; KOG3802; Eukaryota. DR GeneTree; ENSGT00940000157627; -. DR InParanoid; P42571; -. DR OMA; VKTCHLT; -. DR PhylomeDB; P42571; -. DR PRO; PR:P42571; -. DR Proteomes; UP000002494; Chromosome 8. DR Proteomes; UP000234681; Chromosome 8. DR GO; GO:0005829; C:cytosol; IEA:Ensembl. DR GO; GO:0016604; C:nuclear body; IEA:Ensembl. DR GO; GO:0005730; C:nucleolus; IEA:Ensembl. DR GO; GO:0005634; C:nucleus; ISO:RGD. DR GO; GO:0005886; C:plasma membrane; IEA:Ensembl. DR GO; GO:0005667; C:transcription regulator complex; ISO:RGD. DR GO; GO:0003677; F:DNA binding; ISO:RGD. DR GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD. DR GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central. DR GO; GO:0042802; F:identical protein binding; ISO:RGD. DR GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD. DR GO; GO:0043565; F:sequence-specific DNA binding; ISO:RGD. DR GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD. DR GO; GO:0030154; P:cell differentiation; ISO:RGD. DR GO; GO:0008544; P:epidermis development; IDA:RGD. DR GO; GO:0030216; P:keratinocyte differentiation; ISO:RGD. DR GO; GO:0043922; P:negative regulation by host of viral transcription; IEA:Ensembl. DR GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD. DR GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IDA:RGD. DR GO; GO:0042060; P:wound healing; ISO:RGD. DR CDD; cd00086; homeodomain; 1. DR Gene3D; 1.10.10.60; Homeodomain-like; 1. DR Gene3D; 1.10.260.40; lambda repressor-like DNA-binding domains; 1. DR InterPro; IPR009057; Homeobox-like_sf. DR InterPro; IPR017970; Homeobox_CS. DR InterPro; IPR001356; Homeobox_dom. DR InterPro; IPR010982; Lambda_DNA-bd_dom_sf. DR InterPro; IPR013847; POU. DR InterPro; IPR000327; POU_dom. DR InterPro; IPR000972; TF_octamer. DR PANTHER; PTHR11636; POU DOMAIN; 1. DR PANTHER; PTHR11636:SF81; POU DOMAIN, CLASS 2, TRANSCRIPTION FACTOR 3; 1. DR Pfam; PF00046; Homeodomain; 1. DR Pfam; PF00157; Pou; 1. DR PRINTS; PR00029; OCTAMER. DR PRINTS; PR00028; POUDOMAIN. DR SMART; SM00389; HOX; 1. DR SMART; SM00352; POU; 1. DR SUPFAM; SSF46689; Homeodomain-like; 1. DR SUPFAM; SSF47413; lambda repressor-like DNA-binding domains; 1. DR PROSITE; PS00027; HOMEOBOX_1; 1. DR PROSITE; PS50071; HOMEOBOX_2; 1. DR PROSITE; PS00035; POU_1; 1. DR PROSITE; PS00465; POU_2; 1. DR PROSITE; PS51179; POU_3; 1. PE 2: Evidence at transcript level; KW Activator; Alternative splicing; DNA-binding; Homeobox; Nucleus; KW Reference proteome; Transcription; Transcription regulation. FT CHAIN 1..430 FT /note="POU domain, class 2, transcription factor 3" FT /id="PRO_0000100719" FT DOMAIN 176..250 FT /note="POU-specific" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00530" FT DNA_BIND 274..333 FT /note="Homeobox" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00108" FT REGION 1..40 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 60..81 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 129..180 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 248..267 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 355..413 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 19..40 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 129..147 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 250..267 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT VAR_SEQ 1..113 FT /note="MVNLEPMHTEIKMSGDVADSTDARSTFGQVESGNDRNGLDFNRQIKTEDLGD FT TLQQSLSHRPCHLSQGPTMMPGNQMSGDMASLHPLQQLVLVPGHLQSVSQFLLSQTPPG FT QQ -> MVSMFSLSFKWPGFCLFVCLFLCPFVLPCHS (in isoform 2)" FT /evidence="ECO:0000305" FT /id="VSP_002332" FT CONFLICT 55..56 FT /note="QQ -> HE (in Ref. 1; no nucleotide entry)" FT CONFLICT 66..67 FT /note="SQ -> TE (in Ref. 1; no nucleotide entry)" FT CONFLICT 254 FT /note="S -> A (in Ref. 1; no nucleotide entry)" SQ SEQUENCE 430 AA; 46805 MW; 44C12255EDC9C71D CRC64; MVNLEPMHTE IKMSGDVADS TDARSTFGQV ESGNDRNGLD FNRQIKTEDL GDTLQQSLSH RPCHLSQGPT MMPGNQMSGD MASLHPLQQL VLVPGHLQSV SQFLLSQTPP GQQGLQPNLL SFPQQQSTLL LPQTGPGLTS QAVGRPGLSG SSLEPHLEAS QHLPGPKHLP GPGGNDEPTD LEELEKFAKT FKQRRIKLGF TQGDVGLAMG KLYGNDFSQT TISRFEALNL SFKNMCKLKP LLEKWLNDAE SSPSDPSAST PSSYPTLSEV FGRKRKKRTS IETNIRLTLE KRFQDNPKPS SEEISMIAEQ LSMEKEVVRV WFCNRRQKEK RINCPVATPV KPPIYNSRLV SPSGSLGSLS VPPVHSTMPG TVTSSCSPGN NSRPSSPGSG LHASSPTASQ NNSKAAMNPS SAAFNSSGSW YRWNHPAYLH //